Skip to main content
VCbacked
Log inGet Started

Resolution Therapeutics

London, United Kingdom

Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.

$28.9M raised
Oct 2024
Series B
BiopharmaBiotechnologyLife Science

Top Investors

Old College CapitalSyncona Partners LLP

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Resolution Therapeutics

How much funding has Resolution Therapeutics raised?
Resolution Therapeutics has raised $28.9M in total funding. The most recent round was Series B. The last funding was announced in October 2024.
Who are Resolution Therapeutics's investors?
Resolution Therapeutics's investors include Old College Capital, Syncona Partners LLP.
Where is Resolution Therapeutics headquartered?
Resolution Therapeutics is headquartered in London, United Kingdom.
What does Resolution Therapeutics do?
Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
What stage is Resolution Therapeutics at?
Resolution Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Resolution Therapeutics — Funding & Investors." VCBacked, October 3, 2024, https://www.vcbacked.co/company/resolution-therapeutics. Accessed June 17, 2026.
APA
VCBacked. (2024). Resolution Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/resolution-therapeutics
Wikipedia (cite web)
{{cite web |title=Resolution Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/resolution-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego